Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Poseida Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- −8 vs. Q1 2023
- Shares held
- 44.5M
- +388.6K (+0.9%) vs. Q1 2023
- Total value
- $78.4M
- −$57.6M (−42.4%) vs. Q1 2023
- New holders
- 26
- 35 more added
- Sold out
- 34
- 17 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $308.0K |
| Q4 2024 | 116 | $519.2M |
| Q3 2024 | 96 | $153.4M |
| Q2 2024 | 93 | $154.9M |
| Q1 2024 | 91 | $168.6M |
| Q4 2023 | 91 | $152.4M |
| Q3 2023 | 86 | $107.6M |
| Q2 2023 | 94 | $78.4M |
| Q1 2023 | 102 | $136.0M |
| Q4 2022 | 89 | $227.6M |
| Q3 2022 | 68 | $141.8M |
| Q2 2022 | 56 | $58.1M |
| Q1 2022 | 64 | $108.4M |
| Q4 2021 | 66 | $178.4M |
| Q3 2021 | 65 | $190.7M |
| Q2 2021 | 71 | $279.3M |
| Q1 2021 | 62 | $276.3M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Poseida Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −191,064−100.0% | Sold out |
| Crown Advisors Management, Inc. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −146,487−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −122,091−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −102,100−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −47,579−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −43,579−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −43,321−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −37,924−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −36,029−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −34,900−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −33,807−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −32,600−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −32,317−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −24,608−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,806−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −21,859−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −19,617−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −17,717−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −15,792−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −15,592−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −14,563−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −13,697−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −10,197−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −7,860−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −5,264−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −266−100.0% | Sold out |